These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5556232)

  • 1. Tissue viscance in chronic obstructive lung disease.
    Ishikawa S; Cherniack RM
    Am Rev Respir Dis; 1971 Jul; 104(1):32-40. PubMed ID: 5556232
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of parenchymal and airway disease in limiting forced expired flows in chronic obstructive pulmonary disease.
    Boushy SF; North LB; Fagan TJ
    Am Rev Respir Dis; 1973 Oct; 108(4):870-8. PubMed ID: 4741882
    [No Abstract]   [Full Text] [Related]  

  • 3. Airway responsiveness to a bronchodilator aerosol. I. Normal human subjects.
    Watanabe S; Renzetti AD; Begin R; Bigler AH
    Am Rev Respir Dis; 1974 May; 109(5):530-7. PubMed ID: 4823409
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of bronchodilators on the behavior of pulmonary resistance and dynamic compliance as functions of respiratory frequency.
    Cutillo A; Perondi R; Turiel M; Watanabe S; Renzetti AD
    Respiration; 1982; 43(2):88-94. PubMed ID: 7100663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of expiratory airflow limitation in chronic obstructive pulmonary disease associated with 1 -antitrypsin deficiency.
    Black LF; Hyatt RE; Stubbs SE
    Am Rev Respir Dis; 1972 Jun; 105(6):891-9. PubMed ID: 5032709
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between airway resistance FEV 1.0 and viscous work of breathing in patients with chronic obstructive lung disease before and after bronchodilation.
    Quanjer PH; Hilvering C; Tammeling GJ
    Bull Physiopathol Respir (Nancy); 1971; 7(3):539-54. PubMed ID: 5119274
    [No Abstract]   [Full Text] [Related]  

  • 7. The unreliability of indirect lung compliance in healthy subjects and patients with chronic lung disorders.
    Bohadana AB; Jansen da Silva JM; Hannhart B; Peslin R
    Bull Eur Physiopathol Respir; 1981; 17(6):879-89. PubMed ID: 7317664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of expiratory forced flows for determining response to bronchodilator therapy.
    Boushy SF
    Chest; 1972 Nov; 62(5):534-41. PubMed ID: 4563061
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the action of salbutamol and of isoprenaline on airway resistance in 30 patients with obstructive airways disease.
    Sadoul P; Sentissi M
    Postgrad Med J; 1971 Mar; 47():Suppl:111-2. PubMed ID: 5572508
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physiopathologic principles and therapy of bronchial stenosis].
    Herzog H; Keller R
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1971; 199(1):317-46. PubMed ID: 5089601
    [No Abstract]   [Full Text] [Related]  

  • 11. Bronchodilator activity of the prostaglandins E 1 and E 2 .
    Rosenthale ME; Dervinis A; Kassarich J
    J Pharmacol Exp Ther; 1971 Sep; 178(3):541-8. PubMed ID: 4328450
    [No Abstract]   [Full Text] [Related]  

  • 12. Action of isoprenaline on the mechanical properties of lungs and airways in healthy people and patients with obstructive lung diseases.
    Bobbaers H; Stanescu DC; Demedts SM; Clément J; Pardaens J; van de Woestijne KP
    Bull Eur Physiopathol Respir; 1976; 12(4):515-31. PubMed ID: 1087891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of aerosols of prostaglandins E1 and E2 as bronchodilators.
    Kawakami Y; Uchiyama K; Irie T; Murao M
    Eur J Clin Pharmacol; 1973 Aug; 6(2):127-32. PubMed ID: 4588852
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fominoben and central respiratory control].
    Nolte D; Streller SE
    Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:348-5. PubMed ID: 4740111
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dissemination of inhaled air in relation to disorders of the mechanics of respiration in patients with chronic nonspecific diseases of the lungs].
    Abrosimov NZ; Markin EA; Pautov NS
    Ter Arkh; 1974; 46(5):116-9. PubMed ID: 4428381
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of hypocapnia on pulmonary mechanics in normal subjects and in patients with chronic obstructive lung disease.
    Cutillo A; Omboni E; Perondi R; Tana F
    Am Rev Respir Dis; 1974 Jul; 110(1):25-33. PubMed ID: 4834615
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of panting frequency on the plethysmographic determination of thoracic gas volume in chronic obstructive pulmonary disease.
    Shore SA; Huk O; Mannix S; Martin JG
    Am Rev Respir Dis; 1983 Jul; 128(1):54-9. PubMed ID: 6870070
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of inhalation of an atropine derivative (SCH 1000) on airway resistance to flow and on specific conductance in patients with chronic obstructive bronchopneumopathy].
    Anastasatu C; Duţu S
    Ftiziologia; 1974 May; 23(3):305-10. PubMed ID: 4842470
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary resistance and maximal expiratory flowrate following isoprenaline in patients with chronic obstructive lung disease.
    Stănescu DC; Clément J; Van de Woestijne KP
    Thorax; 1973 Nov; 28(6):716-20. PubMed ID: 4787983
    [No Abstract]   [Full Text] [Related]  

  • 20. Lung elastic recoil and airway resistnce as factors limiting forced expiratory flow.
    Penman RW; O'Neill RP; Begley L
    Am Rev Respir Dis; 1970 Apr; 101(4):528-35. PubMed ID: 5439874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.